The Immune Tolerance Institute

The Immune Tolerance Institute Overview

Founded 2007
Founded
Status Acquired/​Merged
Latest Deal Type M&A
Financing Rounds 1

The Immune Tolerance Institute General Information

Description

Provider of research, development and drug discovery services for prevention of autoimmune diseases. The company is focused on the development of new therapies for the treatment of various diseases related to the human immune system, including autoimmune diseases, allergy, asthma, cancer and cardiovascular and infectious diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Other Industries
Drug Discovery
Biotechnology
Acquirer
The David H. Murdock Research Institute
Primary Office
  • 1430 Obrien Drive
  • Suite F
  • Menlo Park, CA 94025
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

The Immune Tolerance Institute Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore The Immune Tolerance Institute‘s full profile, request access.

Request a free trial